The worsening melioidosis outbreak in Queensland has been a focus for the advocacy group. The Australasian Society of Infectious Diseases said cases of melioidosis had been gradually increasing over the last few years.
Read the full article - https://t.co/RkL9Qk8O16
Congratulations Burnet research officer Dr Sophia Schröder for receiving the highest PhD honour at Monash University, the Mollie Holman Award and medal! Dr Schröder's recognition highlights her exceptional efforts, with a remarkable 17 papers published during her candidature.
Very excited to have the final paper from my #PhD published #OpenAccess in @LiverInt
While #HCV DAA treatment is highly effective, it is important to understand why a small minority are not cured. We aimed to do this with data from 🇦🇺🇨🇦🇫🇷🇳🇱🇪🇸🇨🇭
https://t.co/qBUoZ1gVni
A new Burnet study finds introducing an #hepatitisC outreach and treatment program in Australian community pharmacies, could significantly increase testing, diagnosis, and cure those living with the blood-borne virus.
Read more: https://t.co/ZwvYB2CHUl @Josephsdoyle
Dr Irene Kourtis is the new @ASIDANZ CEO. Pres @Josephsdoyle said “Irene’s experience will help ASID cement its position as the peak prof body #ID / clinical #microbiology in Australasia; further develop our strategy; and support members.”
Meet Irene: https://t.co/VGp9mbS94k
@ASIDANZ is hiring a CEO. Join Australasia’s peak professional body for ID and clinical microbiology, representing members in Aus & NZ. Opportunity to work with a diverse Board of specialists in their field.
See: https://t.co/QjWbq3s9U5
Recruitment managed by @fisher_leaders
A huge congratulations to @DrTrishaPeel and team for being awarded the @ACTA_org Clinical Trial of the Year Award tonight!
This important work investigates how effective additional antibiotics are in the prevention of post-joint surgery infection.
More: https://t.co/wPbiNQWD7R
In this double-blind, randomized trial, vancomycin was added to cefazolin as surgical prophylaxis for arthroplasty. Surgical-site infections occurred in 4.5% of vancomycin recipients and 3.5% of placebo recipients. Full results of the ASAP trial: https://t.co/dnEUNp7C77
Just some of the great speakers @Josh_S_Davis@AshaBowen@TrubianoJason we have for @ASIDANZ CRN2024.
Abstracts close 19 May 2024 so if you are an Early or Mid Career #ID#micro clinician researcher in AU Register/ Submit your abstract now👇
See: https://t.co/0EtdivfymX.
Congratulations Prof @Josephsdoyle on his appointment as the new president of Hepatitis Australia.
"I'm excited to be leading the Hepatitis Australia Board as we continue to build momentum toward the 2030 elimination goals,” he said.
https://t.co/uX6AxQBrjq #Infectiousdisease
Registrations / Abstracts open for the 2nd @ASIDANZ Bone & Joint Infection meeting in #GoldCoast#QLD 26-27 July 2024. With Prof Martin McNally, Dr. Robin Patel
@micro_rp, Dr. Desmond Soares, @Josh_S_Davis and more!
See: https://t.co/as73frN4Zo
The research of 2024 Gottschalk Medal recipient Prof Eric Chow (@MonashUni) has shown that the HPV vaccine, the vaccine primarily used to protect women from cervical cancers, can also safeguard men from throat and ano-genital cancers.